Teplizumab's Real-World impact on daily life under the microscope
NCT ID NCT07260110
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 550 people with stage 2 type 1 diabetes in the U.S. to see how teplizumab affects their quality of life, anxiety, and diabetes management. Some participants received teplizumab, others did not, and researchers compare their experiences over time. The goal is to understand the real-world benefits and challenges of treatment, not to test a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigational Site
RECRUITINGSan Francisco, California, 94107, United States